NQO2 and chronic myelogenous leukemia, BCR-ABL1 positive: Recent screens carried out to find off-target proteins that bind to imatinib identified the oxidoreductase NQO2, a flavoprotein that is phosphorylated in a chronic myelogenous leukemia cell line.